PyInvesting

Market research

9EH.F Evolent Health, Inc

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
402M
P/E ratio
Not available
Analyst target
28.33
Dividend yield
Not available
Beta
0.84

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Evolent Health, Inc is currently in a long term uptrend where the price is trading 21.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.

Evolent Health, Inc's total revenue rose by 15.0% to $272M since the same quarter in the previous year.

Its net income has increased by 92.6% to $-15M since the same quarter in the previous year.

Finally, its free cash flow fell by 571.7% to $-19M since the same quarter in the previous year.

Based on the above factors, Evolent Health, Inc gets an overall score of 4/5.